SWAV

ShockWave Medical Inc.

Price

return (12m)

p/e

75.75

p/bv

16.48

DIVIDEND YIELD

0.00%

SWAV price

ShockWave Medical

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SWAV

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals SWAV

Valuation

P/E

75.75

Sector 1.09

Industry -1.78

P/BV

16.48

Sector 1.86

Industry 1.35

P/Revenue (PSR)

15.72

Sector 1.55

Industry 2.25

EV/EBITDA

234.05

Sector -47.62

Industry -42.38

EV/EBIT

247.80

Sector -27.52

Industry -45.58

P/EBITDA

64.05

Sector -32.64

Industry -23.10

P/EBIT

68.20

Sector -43.02

Industry -27.18

P/Total Assets

7.54

Sector 0.87

Industry 0.82

P/Net Current Assets

32.31

Sector -27.09

Industry -72.46

P/Working Capital

10.47

Sector -4.05

Industry -2.10

EPS

4.42

Sector -0.70

Industry -1.11

BVPS

20.32

Sector 4.34

Industry 2.54

Efficiency

Gross Margin

86.99%

Sector 49.36%

Industry 50.48%

EBITDA Margin

25.62%

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

24.19%

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

20.52%

Sector -19.73%

Industry -25.75%

Net Profit Margins

20.75%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.13

Sector 0.13

Industry 0.06

Profitability

ROE

21.75%

Sector -24.32%

Industry -33.33%

ROA

9.95%

Sector -24.41%

Industry -45.72%

ROIC

34.61%

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

13.81

Sector 1.90

Industry 2.51

Net Debt / EBITDA

13.07

Sector -4.96

Industry -8.98

Net Debt / EBIT

13.84

Sector -3.08

Industry -37.38

Net Debt / Equity

0.97

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.97

Sector -0.74

Industry -0.56

Equity/Assets

0.46

Sector 0.46

Industry 0.52

Liabilities/Assets

0.46

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

27.15%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals SWAV

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF ShockWave Medical ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$44.95

Upside

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SWAV ShockWave Medical Inc.	$0.00	-	0.00%	75.75	16.48	21.75%	20.75%
ISRG Intuitive Surgical Inc.	$392.49	-9.49%	0.00%	44.01	7.60	17.26%	28.62%
ABT Abbott Laboratories	$102.63	-21.99%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.33	1.59%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$43.52	-55.82%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$87.47	-27.00%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$227.07	-15.55%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$512.11	-20.09%	0.00%	35.48	25.07	70.67%	25.03%
COHR Coherent Inc.	$308.78	198.60%	0.00%	75.62	5.36	7.09%	11.19%
SYK Stryker Corp.	$276.81	-25.56%	1.26%	28.38	4.41	15.55%	14.43%
PHG Koninklijke Philips NV	$24.65	-8.23%	4.11%	18.19	1.78	9.80%	6.30%
INMD InMode Ltd.	$14.32	-4.12%	0.00%	10.90	1.34	12.32%	20.69%
DXCM DexCom Inc.	$88.64	15.96%	0.00%	33.89	12.92	38.14%	20.12%
BDX Becton Dickinson and Company	$180.03	-1.10%	2.34%	52.21	2.01	3.86%	6.30%
EW Edwards Lifesciences Corp.	$88.26	17.37%	0.00%	50.69	4.74	9.36%	15.41%
ALGN Align Technology Inc.	$147.59	14.02%	0.00%	27.43	2.68	9.77%	9.99%
SNN Smith & Nephew PLC	$27.54	-23.70%	2.80%	19.48	4.52	23.22%	9.83%
IRMD iRadimed Corporation	$82.52	17.96%	1.54%	45.76	10.37	22.66%	26.70%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SWAV Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT ShockWave Medical

ShockWave Medical Inc.

Average Investor10 user rating

4.0 (0 people)

United States

17 years

Founded: 2009

2019

Time since IPO - 7 years

449

Employees

ShockWave Medical Inc. (United States) is listed on the Nasdaq and has a market capitalization of $12.39 billion, with shareholders equity totaling $751.76 million.

The company employs approximately 449 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, ShockWave Medical Inc. reported $787.98 million in revenue, generating net income of $163.50 million.

Key financial metrics include a P/E ratio of 75.75, a price-to-book (P/B) ratio of 16.48, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SWAV.

Market cap

$12.39 billion

Net worth

$751.76 million

$751,760,000.00

Assets

$1.64 billion

$1,643,750,000.00

Total Shares Outstanding

37.00 million

37,000,000

Average Daily Trading Volume

$1.45 million

$1,452,484.58

Sector

Health

Industry

Medical Supplies and Equipment

SWAV

SWAV revenue and profits

Financial Results SWAV

DRAG THE FRAME TO SEE MORE DATA

SWAV cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.45 21,79% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.31 --3,58% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.99 107,71% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$384.07 54,21% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.38 --7,54% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,142.35 52,87% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$429.56 7,48% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$139.78 15,92% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35